<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37239465</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1105</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes14051105</ELocationID><Abstract><AbstractText Label="OBJECTIVES">CD11B/ITGAM (Integrin Subunit &#x3b1; M) mediates the adhesion of monocytes, macrophages, and granulocytes and promotes the phagocytosis of complement-coated particles. Variants of the ITGAM gene are candidates for genetic susceptibility to systemic lupus erythematosus (SLE). SNP rs1143679 (R77H) of CD11B particularly increases the risk of developing SLE. Deficiency of CD11B is linked to premature extra-osseous calcification, as seen in the cartilage of animals with osteoarthritis. Serum calcification propensity measured by the T50 test is a surrogate marker for systemic calcification and reflects increased cardiovascular (CV) risk. We aimed to assess whether the CD11B R77H gene variant is associated with a higher serum calcification propensity (i.e., a lower T50 value) in SLE patients compared to the wild-type allele (WT).</AbstractText><AbstractText Label="METHODS">Cross-sectional study incorporating adults with SLE genotyped for the CD11B variant R77H and assessed for serum calcification propensity with the T50 method. Participants were included in a multicenter trans-disciplinary cohort and fulfilled the 1997 revised American College of Rheumatology (ACR) criteria for SLE. We used descriptive statistics for comparing baseline characteristics and sequential T50 measurements in subjects with the R77H variant vs. WT CD11B.</AbstractText><AbstractText Label="RESULTS">Of the 167 patients, 108 (65%) were G/G (WT), 53 (32%) were G/A heterozygous, and 6 (3%) were A/A homozygous for the R77H variant. A/A patients cumulated more ACR criteria upon inclusion (7 &#xb1; 2 vs. 5 &#xb1; 1 in G/G and G/A; <i>p</i> = 0.02). There were no differences between the groups in terms of global disease activity, kidney involvement, and chronic renal failure. Complement C3 levels were lower in A/A individuals compared to others (0.6 &#xb1; 0.08 vs. 0.9 &#xb1; 0.25 g/L; <i>p</i> = 0.02). Baseline T50 did not differ between the groups (A/A 278 &#xb1; 42' vs. 297 &#xb1; 50' in G/G and G/A; <i>p</i> = 0.28). Considering all sequential T50 test results, serum calcification propensity was significantly increased in A/A individuals compared to others (253 &#xb1; 50 vs. 290 &#xb1; 54; <i>p</i> = 0.008).</AbstractText><AbstractText Label="CONCLUSIONS">SLE patients with homozygosity for the R77H variant and repeated T50 assessment displayed an increased serum calcification propensity (i.e., a lower T50) and lower C3 levels compared to heterozygous and WT CD11B, without differing with respect to global disease activity and kidney involvement. This suggests an increased CV risk in SLE patients homozygous for the R77H variant of CD11B.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halfon</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Transplantation Center, Lausanne University Hospital, 1010 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physiology, Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehirchiou</LastName><ForeName>Driss</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0004-2275-9859</Identifier><AffiliationInfo><Affiliation>Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandian</LastName><ForeName>Vishnuprabu Durairaj</ForeName><Initials>VD</Initials><AffiliationInfo><Affiliation>Department of Physiology, Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahdal</LastName><ForeName>Suzan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, University Hospital Bern Inselspital, 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh-Do</LastName><ForeName>Uyen</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, University Hospital Bern Inselspital, 3010 Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Systemic Lupus Erythematosus Cohort Study.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasch</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, Linz University, 4040 Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribi</LastName><ForeName>Camillo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0446-9741</Identifier><AffiliationInfo><Affiliation>Swiss Systemic Lupus Erythematosus Cohort Study.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busso</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509295">ITGAM protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039481">CD11b Antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002114" MajorTopicYN="Y">Calcinosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039481" MajorTopicYN="Y">CD11b Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD11B</Keyword><Keyword MajorTopicYN="N">ITGAM</Keyword><Keyword MajorTopicYN="N">calcification propensity</Keyword><Keyword MajorTopicYN="N">complement</Keyword><Keyword MajorTopicYN="N">lupus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37239465</ArticleId><ArticleId IdType="pmc">PMC10218643</ArticleId><ArticleId IdType="doi">10.3390/genes14051105</ArticleId><ArticleId IdType="pii">genes14051105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foster M.H. T Cells and B Cells in Lupus Nephritis. Semin. Nephrol. 2007;27:47&#x2013;58. doi: 10.1016/j.semnephrol.2006.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2006.09.007</ArticleId><ArticleId IdType="pmc">PMC1997284</ArticleId><ArticleId IdType="pubmed">17336688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedar A.M., Stradner M.H., Roessler A., Goswami N. Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis. J. Clin. Med. 2021;10:4427. doi: 10.3390/jcm10194427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194427</ArticleId><ArticleId IdType="pmc">PMC8509415</ArticleId><ArticleId IdType="pubmed">34640445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahdal S., Devetzis V., Chalikias G., Tziakas D., Chizzolini C., Ribi C., Trendelenburg M., Eisenberger U., Hauser T., Pasch A., et al. Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus. PLoS ONE. 2018;13:e0188695. doi: 10.1371/journal.pone.0188695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188695</ArticleId><ArticleId IdType="pmc">PMC5783342</ArticleId><ArticleId IdType="pubmed">29364894</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.Q., Khan I., Gupta V. CD11b Activity Modulates Pathogenesis of Lupus Nephritis. Front. Med. 2018;5:52. doi: 10.3389/fmed.2018.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00052</ArticleId><ArticleId IdType="pmc">PMC5862812</ArticleId><ArticleId IdType="pubmed">29600248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitagawa A., Tsuboi N., Yokoe Y., Katsuno T., Ikeuchi H., Kajiyama H., Endo N., Sawa Y., Suwa J., Sugiyama Y., et al. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kidney Int. 2019;95:680&#x2013;692. doi: 10.1016/j.kint.2018.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.10.025</ArticleId><ArticleId IdType="pubmed">30712924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Bello J., Sun C., Valencia-Pacheco G., Singh B., Barbosa-Cobos R.E., Saavedra M.A., L&#xf3;pez-Villanueva R.F., Nath S.K. ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico. PLoS ONE. 2019;14:e0224543. doi: 10.1371/journal.pone.0224543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0224543</ArticleId><ArticleId IdType="pmc">PMC6881022</ArticleId><ArticleId IdType="pubmed">31774828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehirchiou D., Bernabei I., Chobaz V., Castelblanco M., H&#xfc;gle T., So A., Zhang L., Busso N., Nasi S. CD11b Signaling Prevents Chondrocyte Mineralization and Attenuates the Severity of Osteoarthritis. Front. Cell Dev. Biol. 2020;8:611757. doi: 10.3389/fcell.2020.611757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.611757</ArticleId><ArticleId IdType="pmc">PMC7775404</ArticleId><ArticleId IdType="pubmed">33392201</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Yang Y. Integrated Gene Expression Profiling Analysis Reveals Potential Molecular Mechanisms and Candidate Biomarkers for Early Risk Stratification and Prediction of STEMI and Post-STEMI Heart Failure Patients. Front. Cardiovasc. Med. 2021;8:736497. doi: 10.3389/fcvm.2021.736497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.736497</ArticleId><ArticleId IdType="pmc">PMC8702808</ArticleId><ArticleId IdType="pubmed">34957234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribi C., Trendelenburg M., Gayet-Ageron A., Cohen C., Dayer E., Eisenberger U., Hauser T., Hunziker T., Leimgruber A., Lindner G., et al. The Swiss Systemic lupus erythematosus Cohort Study (SSCS)&#x2014;Cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland. Swiss. Med. Wkly. 2014;144:w13990. doi: 10.4414/smw.2014.13990.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2014.13990</ArticleId><ArticleId IdType="pubmed">25115978</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasch A., Farese S., Gr&#xe4;ber S., Wald J., Richtering W., Floege J., Jahnen-Dechent W. Nanoparticle-based test measures overall propensity for calcification in serum. J. Am. Soc. Nephrol. 2012;23:1744&#x2013;1752. doi: 10.1681/ASN.2012030240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012030240</ArticleId><ArticleId IdType="pmc">PMC3458464</ArticleId><ArticleId IdType="pubmed">22956818</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasch A., Block G.A., Bachtler M., Smith E.R., Jahnen-Dechent W., Arampatzis S., Chertow G.M., Parfrey P., Ma X., Floege J. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin. J. Am. Soc. Nephrol. 2017;12:315&#x2013;322. doi: 10.2215/CJN.04720416.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04720416</ArticleId><ArticleId IdType="pmc">PMC5293330</ArticleId><ArticleId IdType="pubmed">27940458</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.R., Ford M.L., Tomlinson L.A., Bodenham E., McMahon L.P., Farese S., Rajkumar C., Holt S.G., Pasch A. Serum calcification propensity predicts all-cause mortality in predialysis, C.K.D. J. Am. Soc. Nephrol. 2014;25:339&#x2013;348. doi: 10.1681/ASN.2013060635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013060635</ArticleId><ArticleId IdType="pmc">PMC3904573</ArticleId><ArticleId IdType="pubmed">24179171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Nishi H., Travers R., Tsuboi N., Martinod K., Wagner D.D., Stan R., Croce K., Mayadas T.N. Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo. Blood. 2012;120:4421&#x2013;4431. doi: 10.1182/blood-2011-12-401133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-12-401133</ArticleId><ArticleId IdType="pmc">PMC3507149</ArticleId><ArticleId IdType="pubmed">22955924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruef J., Kuehnl P., Meinertz T., Merten M. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation. Platelets. 2008;19:359&#x2013;364. doi: 10.1080/09537100802105040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537100802105040</ArticleId><ArticleId IdType="pubmed">18791942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zehr K.J., Herskowitz A., Lee P.C., Kumar P., Gillinov A.M., Baumgartner W.A. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation. 1994;57:900&#x2013;905. doi: 10.1097/00007890-199403270-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-199403270-00023</ArticleId><ArticleId IdType="pubmed">8154039</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban A., Leira E.C. Neurological Complications in Patients with Systemic Lupus Erythematosus. Curr. Neurol. Neurosci. Rep. 2019;19:97. doi: 10.1007/s11910-019-1012-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-1012-1</ArticleId><ArticleId IdType="pubmed">31773306</ArticleId></ArticleIdList></Reference><Reference><Citation>Feh&#xe9;rv&#xe1;ri M., Krepuska M., Sz&#xe9;plaki G., Apor A., S&#xf3;tonyi P., Prohaszka Z., Acs&#xe1;dy G., Szeberin Z. The level of complement C3 is associated with the severity of atherosclerosis but not with arterial calcification in peripheral artery disease. Int. Angiol. 2014;33:35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">24452084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pluquet M., Kamel S., Choukroun G., Liabeuf S., Laville S.M. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review. Toxins. 2022;14:637. doi: 10.3390/toxins14090637.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins14090637</ArticleId><ArticleId IdType="pmc">PMC9501050</ArticleId><ArticleId IdType="pubmed">36136575</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Zhao M., Hirankarn N., Lau C.S., Mok C.C., Chan T.M., Wong R.W., Lee K.W., Mok M.Y., Nin Wong S., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 2009;18:2063&#x2013;2070. doi: 10.1093/hmg/ddp118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp118</ArticleId><ArticleId IdType="pmc">PMC2678927</ArticleId><ArticleId IdType="pubmed">19286673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>